fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Budesonide

All products: general benefit

Rhinocort Aqua · DIN 02231923 · 64 mcg/Metered Dose · Nas Sp-120 Dose Pk

General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Rhinocort Aqua · DIN 02231923 Manufacturer: McNeil Consumer Products Co.; listing date 1998-12-31 Health Canada: Marketed since 2026-10-26 · brand RHINOCORT AQUA · ATC R01AD05 BUDESONIDE · form Spray (metered-dose) · route Nasal · ingredients BUDESONIDE 64 MCG/ACT · company Kenvue canada inc. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Rhinocort Aqua: Formulary list price $11.04 per unit (the source does not state the unit; exact figure $11.0400). What the ministry pays, not the patient.

Ministry pays: $11.0400 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada); extract: Marketed March 9, 2026; live record preferred: Marketed October 26, 2026 (checked November 17, 2026) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02231923)

Source record
DIN 02231923: Rhinocort Aqua Raw flags: sec3=Y Item: 520800039; group id 591; item number 1548; lccId None; manufacturer id MCL Source form: Nas Sp-120 Dose Pk; strength: 64mcg/Metered Dose Recorded listing: General benefit Source prices (unrounded): $11.0400; ministry $11.0400 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02231923 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada); extract: Marketed March 9, 2026; live record preferred: Marketed October 26, 2026 (checked November 17, 2026) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=51375
Shortage status: not checked (no credentials)

Other products in the same Health Canada class (R01AD): coverage varies; not interchangeable

  • Beclomethasone dipropionate (Mylan-Beclo AQ): general benefit, not a benefit
  • Azelastine + fluticasone (Dymista): not a benefit
  • Fluticasone (Flonase): not a benefit
  • Mometasone furoate (Nasonex): not a benefit
  • Triamcinolone acetonide (Nasacort AQ): not a benefit
Other drugs in the same formulary class (52:08 Anti-Inflammatory Agents) and how they are covered

Matched class: 52:08 Anti-Inflammatory Agents

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: DEXAMETHASONE, FLUMETHASONE PIVALATE & IODOCHLORHYDROXYQUIN, FLUOROMETHOLONE, FLUOROMETHOLONE ACETATE, KETOROLAC TROMETHAMINE, LODOXAMIDE TROMETHAMINE Some products covered without a code (check the product listing): BECLOMETHASONE DIPROPIONATE, PREDNISOLONE ACETATE 52:08 Anti-Inflammatory Agents

BECLOMETHASONE DIPROPIONATE

· 3 products · General benefit (2), Listed, not a benefit (1) · strengths: 50mcg · Nas-Sp-200 Dose Pk

AZELASTINE HCL & FLUTICASONE PROPIONATE

· 3 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 137mcg/Actuation&50mcg/Actuation · Nas-Sp-120 Dose Pk

FLUTICASONE PROPIONATE

· 4 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 50mcg/Actuation · Nas Sp-120 Dose Pk

MOMETASONE FUROATE

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 50mcg/Dose · Nas Sp-140 Dose Pk

TRIAMCINOLONE ACETONIDE

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 55mcg/Metered Dose · Nas Sp-120 Dose Pk (with Preservative)

DEXAMETHASONE

· 2 products · General benefit · strengths: 0.1% · Oph Oint-3.5g Pk, Oph Susp

FLUMETHASONE PIVALATE & IODOCHLORHYDROXYQUIN

· 1 products · General benefit · strengths: 0.02% & 1% · Ot Sol

FLUOROMETHOLONE

· 1 products · General benefit · strengths: 0.1% · Oph Susp

FLUOROMETHOLONE ACETATE

· 1 products · General benefit · strengths: 0.1% · Oph Susp

KETOROLAC TROMETHAMINE

· 3 products · General benefit · strengths: 0.5%, 0.45% w/v · Oph Sol, Oph Sol-0.4mL Vial Pk (Preservative-Free)

LODOXAMIDE TROMETHAMINE

· 1 products · General benefit · strengths: 0.1% · Oph Sol

PREDNISOLONE ACETATE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 1% · Oph Susp Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 52:08 and 2 more
Full class listing Related classes: 52:04 Anti-Infectives, 52:16 Local Anesthetics, 52:20 Miotics, 52:24 Mydriatics, 52:32 Vasoconstrictors, 52:36 Other Eye, Ear, Nose and Throat Agents Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE Patients with bronchial asthma:  In patients who require inhaled steroids;  In patients for whom a reduction of systemic glucocorticoids is desirable. https://pdf.hres.ca/dpd_pm/00042073.PDF PM date: November 8, 2017 Source product: PULMICORT TURBUHALER; DIN 00851752; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.